Secondly, in vitro and in vivo experiments showed that ACE2 overexpression inhibits HCC tumor growth through blocking the aerobic glycosis in HCC via Ang (1–7)/Mas Receptor axis with the downstream signaling cascade of p-SHP2/ROS/HIF1α axis [325]. This evidence concerns the gene ANGPT1 and hepatocellular carcinoma.